Anjali Singh

Finance Minister Nirmala Sitharaman announced measures in the Union Budget 2026-27 to boost medical tourism, including support for five regional hubs in partnership with states and the private sector

US generics remain under pressure while API revenues decline during the quarter

Pharma major reports double-digit growth in Q3 as India and North America lead performance, though profit and revenue declined sequentially

Two-wheeler maker records its highest-ever quarterly revenue and profit in Q3 FY26, aided by premium motorcycles, strong EV sales and a rebound in exports

The company attributed the weaker performance largely to continued inventory destocking in one of its large on-patent commercial products, affecting its CDMO business

India-EU FTA could transform India's CDMO sector by cutting pharma tariffs, easing regulations and deepening Indian integration into Europe's drug supply chains

A new NITI Aayog assessment said tyre production is projected to double over the next decade, significantly increasing the volume of discarded tyres

Industry executives say incentives continue to play a role in easing upfront cost concerns for price-sensitive buyers

India has entered the first phase of generic semaglutide approvals, with CDSCO clearing multiple formulations for obesity and diabetes, paving the way for lower-cost GLP-1 therapies

Syngene trims FY26 revenue guidance by up to 5% as inventory correction for veterinary drug Librela hits profits, even as core research and CDMO business grows

Bets on respiratory product launches and peptides for growth

Librela inventory correction and one-time labour code costs weigh on earnings

Rising medical costs and insurance gaps are pushing more urban Indians to take personal loans for healthcare, with reliance highest in Tier-I cities, a Paisabazaar study shows

Study of doctors flags growing concern over worsening air quality in Indian cities, linking high AQI levels to chronic illnesses, rising healthcare costs and poor financial preparedness among patients

Toyota Kirloskar Motor enters India's EV market with the Urban Cruiser Ebella, a born-electric SUV developed with Maruti Suzuki, as it pursues a multi-technology electrification strategy

Lamborghini delivered a record 10,747 vehicles globally in 2025, crossing the 10,000 mark for the first time, though sales in India slipped marginally amid uneven market conditions

India's electric passenger vehicle registrations have surged over five years, with southern states consistently contributing about one-third of volumes

Sun Pharmaceutical said reports of a $10 billion acquisition of US-based Organon are speculative, adding there is no material information requiring disclosure to exchanges

Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production following USFDA observations

Mahindra's newly launched XEV 9S and XUV 7XO SUVs drew strong initial demand, with nearly 94,000 bookings on the first day, translating into orders worth over Rs 20,500 crore